UC Davis Cohort of Pre-Malignant and Malignant Gastro-Intestinal DisEases Study
Part of paid clinical trials in Sacramento, California.
- Sponsor
- University of California, Davis
- Study ID
- NCT05021029
- Status
- Enrolling By Invitation
Conditions
- Atrophic Gastritis
- Autoimmune Gastritis
- Chronic Gastritis
- Intestinal Dysplasia
- Intestinal Metaplasia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
To establish a prospective cohort of individuals diagnosed with gastric pre-malignant conditions (chronic gastritis, atrophic gastritis, autoimmune gastritis, intestinal metaplasia, intestinal dysplasia) to monitor and study disease progression. The Investigators will like to survey cohort participants for lifestyle behaviors and environmental exposures associated with gastric pre-malignancy and cancer. Analyzing patient biospecimens to identify and characterize host and microbiome biomarkers associated with initiation and progression of gastric pre-malignancies.
Key Dates
- Start date
- Jul 13, 2021
- Status verified
- Nov 2025
- Primary completion
- Oct 31, 2026
- Completion
- Oct 31, 2026
Study Design
- Enrollment
- 1,000 participants (estimated)
Primary Outcome Measure
Pre-malignant progression [ Time Frame: 2024 ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California Davis Comprehensive Cancer Center | Sacramento | California | 95817 | - |
Find similar trials in Sacramento, CA
Related Studies
- The GAstric Precancerous Conditions StudyRecruiting · Stanford University · Stanford, California